2016-2017 Recommendations For Use of LAIV Influenza Vaccine

Shared from our colleagues at the California Immunization Coalition:

In June the CDC’s Advisory Committee on Immunization Practices (ACIP) meeting, the Committee voted that live attenuated influenza vaccine (LAIV), also known as the “nasal spray” flu vaccine, should not be used during the 2016-2017 flu season. ACIP continues to recommend annual flu vaccination, with either the inactivated influenza vaccine (IIV) or recombinant influenza vaccine (RIV), for everyone 6 months and older. This ACIP vote is based on data showing poor or relatively lower effectiveness of LAIV from 2013 through 2016.

Additional information will be made available in the coming days and weeks and CIC will post on Facebook and Twitter along with direct communications as appropriate.

Read more directly from the CDC Press Release:  

“ACIP votes down use of LAIV for 2016-2017 flu season.”


ACIP is a panel of immunization experts that advises the Centers for Disease Control and Prevention (CDC). To learn more about ACIP and future meeting dates, go to: http://www.cdc.gov/vaccines/acip/index.html